Your browser doesn't support javascript.
loading
Prognostic factors of the synovial sarcoma of the extremities: imaging does matter.
Tordjman, Mickael; Honoré, Charles; Crombé, Amandine; Bouhamama, Amine; Feydy, Antoine; Dercle, Laurent; Haddag, Leila; Bouché, Pierre-Alban; Ngo, Carine; Le Cesne, Axel; Blay, Jean-Yves; Mir, Olivier; Brahmi, Mehdi; Martin, Charlotte; Karanian, Marie; Ammari, Samy; Kind, Michele; Audard, Virginie; Le Loarer, François; Rabiee, Behnam; Italiano, Antoine; Boudou-Rouquette, Pascaline; Biau, David; Balleyguier, Corinne; Larousserie, Frederique; Drapé, Jean-Luc; Mihoubi, Fadila.
Afiliação
  • Tordjman M; Department of Radiology, Hopital Cochin, APHP, 27 rue du Faubourg Saint Jacques, 75014, Paris, France. mickael_tordjman@hotmail.com.
  • Honoré C; Department of Surgery, Gustave Roussy Cancer campus, Villejuif, France.
  • Crombé A; Department of Radiology, Institut Bergonié, Bordeaux, France.
  • Bouhamama A; Department of Radiology, Centre Léon Bérard, Lyon, France.
  • Feydy A; Department of Radiology, Hopital Cochin, APHP, 27 rue du Faubourg Saint Jacques, 75014, Paris, France.
  • Dercle L; Department of Radiology, New York-Presbyterian, Columbia University Irving Medical Center, New York, NY, USA.
  • Haddag L; Department of Radiology, Gustave Roussy Cancer campus, Villejuif, France.
  • Bouché PA; Department of Orthopaedic Surgery, Hopital Cochin, APHP, Paris, France.
  • Ngo C; Department of Biostatistics and Medical Information, Hopital Saint Louis, APHP, Université de Paris, ECSTRA Team, UMR U1153, INSERM, Paris, France.
  • Le Cesne A; Department of Pathology, Gustave Roussy Cancer campus, Villejuif, France.
  • Blay JY; Department of Oncology, Gustave Roussy Cancer campus, Villejuif, France.
  • Mir O; Department of Oncology, Centre Léon Bérard, Lyon, France.
  • Brahmi M; Department of Oncology, Gustave Roussy Cancer campus, Villejuif, France.
  • Martin C; Department of Oncology, Centre Léon Bérard, Lyon, France.
  • Karanian M; Department of Radiology, Hopital Cochin, APHP, 27 rue du Faubourg Saint Jacques, 75014, Paris, France.
  • Ammari S; Department of Pathology, Centre Léon Bérard, Lyon, France.
  • Kind M; Department of Radiology, Gustave Roussy Cancer campus, Villejuif, France.
  • Audard V; Department of Radiology, Institut Bergonié, Bordeaux, France.
  • Le Loarer F; Department of Pathology, Hopital Cochin, APHP, Paris, France.
  • Rabiee B; Department of Pathology, Institut Bergonié, Bordeaux, France.
  • Italiano A; Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA.
  • Boudou-Rouquette P; Department of Oncology, Institut Bergonié, Bordeaux, France.
  • Biau D; Department of Oncology, Hopital Cochin, APHP, Paris, France.
  • Balleyguier C; Department of Orthopaedic Surgery, Hopital Cochin, APHP, Paris, France.
  • Larousserie F; Department of Radiology, Gustave Roussy Cancer campus, Villejuif, France.
  • Drapé JL; Department of Pathology, Hopital Cochin, APHP, Paris, France.
  • Mihoubi F; Department of Radiology, Hopital Cochin, APHP, 27 rue du Faubourg Saint Jacques, 75014, Paris, France.
Eur Radiol ; 33(2): 1162-1173, 2023 Feb.
Article em En | MEDLINE | ID: mdl-35980435
ABSTRACT

OBJECTIVES:

Synovial sarcomas (SS) of the extremities are rare soft tissue sarcomas that are more common in young adults. We deciphered the imaging phenotype of SS with the aim to determine if imaging could provide an incremental value to currently known prognostic factors (PF)-age and histological grade-to predict long-term overall survival (OS).

METHODS:

This retrospective multicenter study included consecutive pediatric and adult patients with synovial sarcomas of the extremities from December 2002 to August 2020. Inclusion criteria were (i) a follow-up greater than 5 years and (ii) available pre-therapeutic MRI. A subset analysis included MRI and CT-scan. Clinical, pathological, and imaging variables were collected in all patients. The primary endpoint was to evaluate the association of these variables with OS using univariate and multivariate Cox regressions.

RESULTS:

Out of 428 patients screened for eligibility, 98 patients (mean age 37.1 ± 15.2 years) were included (MRI n = 98/98, CT scan n = 34/98; 35%). The median OS was 75.25 months (IQR = 55.50-109.12) and thirty-six patients (n = 36/98;37%) died during follow-up. The recurrence rate was 12.2% (n =12/98). SS lesions were mostly grade 2 (57/98; 58%). On MRI, SS had a mean long-axis diameter of 67.5 ± 38.3 mm. On CT scan, 44% (15/34) were calcified. Grade (hazard ratio [HR] = 2.71; 95%CI = 1.30-5.66; p = 0.008), size of the lesions evaluated on MRI (HR = 1.02; 95% CI = 1.01-1.03; p < 0.001), and calcifications on CT scan (HR = 0.10; 95% CI = 0.02-0.50; p = 0.005) were independent PF of OS.

CONCLUSIONS:

This study demonstrated that imaging biomarkers can be used to predict long-term outcome in patients with SS. Strikingly, the presence of calcifications on CT scan is associated with favorable outcome and provides an incremental value over existing PF such as age, grade, and size. KEY POINTS • Beyond its diagnostic value, MRI is a pre-operative prognostic tool in synovial sarcomas of the extremities since the size of the lesion is an important prognostic factor. • Calcifications on CT scans are independently and significantly associated with prolonged overall survival.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Sarcoma Sinovial Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Sarcoma Sinovial Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França